A crash closed the right northbound tube of the Fort McHenry Tunnel, backing up Interstate 95 through Baltimore Friday ...

StockNews.com cut shares of Arbutus Biopharma (NASDAQ:ABUS – Free Report) from a hold rating to a sell rating in a research report released on Thursday morning. A number of other equities research ...

Genevant Sciences and Arbutus Biopharma (ABUS) filed five international lawsuits seeking to enforce patents protecting their innovative LNP ...

Feb. 25, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on infectious disease ...

The ancient Greeks had a diet rich in natural ingredients, many of which are now celebrated as superfoods for their health ...

An 18-storey, mass-timber hotel tower with 168 guest rooms is proposed for 1500-1580 West 3rd Avenue, near Granville Island ...

WARMINSTER, Pa., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Arbutus Biopharma Corporation (Nasdaq: ABUS) (“Arbutus” or the “Company”), a clinical-stage biopharmaceutical company focused on ...

Sun, 09 Mar 2025 05:55:04 GMT (Reuters) - Arbutus Biopharma Corp said on Monday it had filed a lawsuit against Moderna Inc seeking damages for infringement of patents related to its COVID-19 vaccine.

All seven members of Arbutus Biopharma's board have resigned and been replaced by five new members, including the company's new chief executive. The virology-focused biotech company said Tuesday ...

March 03, 2025 (GLOBE NEWSWIRE) -- Genevant Sciences, a leading nucleic acid delivery company with world-class platforms and a robust lipid nanoparticle (LNP) patent portfolio (a subsidiary of Roivant ...